Approaching Clinical Trials Where the Air Hurts Your Face
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges...
Trending menu:
-
![]()
Industry Viewpoints: How to Optimize Direct-to-Patient Shipping
-
![]()
Annex 16 and Achieving QP Release for EU Clinical Trials: Adapting Operationally to Meet the Latest Requirements
-
![]()
The Top 5: August 2018
-
![]()
What are the Fundamentals of a Robust Cold Chain Strategy?
-
![]()
Industry Viewpoints: Implementing an Automated Receipt Process for Temperature-Monitored Shipments
-
![]()
Expert Insights: NIH Scientists Endorse Platform Manufacturing to Shorten Vaccine Development Timelines
Most Read
Latest Content
Approaching Clinical Trials Where the Air Hurts Your Face
Colin Enz, CSM & Russell Brierley, Lupin Research Inc, outline the key challenges involved in handling cryogenic pharmaceutical products
Industry Viewpoints: How to Optimize Direct-to-Patient Shipping
CTA’s Natacha Girard speaks to Florentina Silva, External Operations Manager, about the challenges of direct-to-patient shipping
Annex 16 and Achieving QP Release for EU Clinical Trials: Adapting Operationally to Meet the Latest Requirements
Robert Bronstein, Dynavax Technologies, discusses Annex 16 and what every clinical supply chain manager needs to know to avoid potential QP release pitfalls
The Top 5: August 2018
CTA highlights the best articles from the month of August 2018
What are the Fundamentals of a Robust Cold Chain Strategy?
CTA Editor Henry Kerali explores the topic of temperature excursions asking what constitutes a robust cold chain strategy
Industry Viewpoints: Implementing an Automated Receipt Process for Temperature-Monitored Shipments
Henk Dieteren, Senior Clinical Supply Manager, Grünenthal, speaks to CTA Editor Henry Kerali about monitoring temperature-sensitive shipments
The Pros and Cons of Just in Time Labelling
Guglielmo Migliori runs the rule on the advantages and disadvantages of Just-in-Time labelling
Falsified Medicines Directive – Preparing for Global Compliance in Packaging and Labelling
CTA’s Lu Tikrity explores the implications of the Falsified Medicines Directive as the deadline looms ever larger
Expert Insights: NIH Scientists Endorse Platform Manufacturing to Shorten Vaccine Development Timelines
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, explains how the development of vaccines must change to combat viral outbreaks
Temperature Sensitive Challenges in Last Mile Distribution
Erik Agterhuis, Formerly of Mylan, describes the inherent challenges behind last mile distribution
Latest News
Go Top
